Recombinant Human Anti-MAPT Antibody (clone Tilavonemab) Preis auf Anfrage
Artikelnummer:
CRB-VS-0923-FY255-1
Hersteller Artikelnummer:
VS-0923-FY255
Alternativnummer:
CRB-VS-0923-FY255-1
Hersteller:
Creative Biolabs
Kategorie:
Antikörper
Tilavonemab is a humanized IgG4 antibody that was developed by C2N Diagnostics and AbbVie to treat tauopathies. It specifically targets an aggregated, extracellular form of pathological tau by binding to amino acids 25-30 in taus N-terminus. By blocking the uptake of tau aggregates in human and mouse neurons, Tilavonemab effectively reduces brain atrophy. This particular form of tau is believed to play a role in the transneuronal propagation of tau pathology in cell-based and mouse models, potentially explaining the characteristic progression of tau pathology in Alzheimers disease.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten